REPROCELL
Regenerative Medicine · Drug Discovery

REPROCELL news and milestones

REPROCELL: 8 headlines on record, 1 headline in the last 90 days.

Data updated Nov 18, 2026 · Back to the company report
8Headlines
1In 90 days
0Milestones

Headlines

Sep 252026
News · investing.com
Aug 202026
News · uk.investing.com
Jun 242026
News · YahooFinance
REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal, for which the…
Jan 282026
Press release · PRNewswire
/PRNewswire/ -- REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines...
Oct 22, 20252025
News · YahooFinance
REPROCELL is a leader in producing clinically relevant human induced pluripotent stem cells (hiPSCs). These hiPSCs are generated from healthy donors that have been ethically cons…
Sources: the outlets named on each headline, each story once

How to cite

REPROCELL, News. Alion, Nov 18, 2026. https://alion.io/company/reprocell/news

.json · .md · CC BY-SA 4.0